First Time Loading...

Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 177.5 SEK -0.45% Market Closed
Updated: May 13, 2024

Intrinsic Value

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. [ Read More ]

The intrinsic value of one VITR stock under the Base Case scenario is 143.96 SEK. Compared to the current market price of 177.5 SEK, Vitrolife AB is Overvalued by 19%.

Key Points:
VITR Intrinsic Value
Base Case
143.96 SEK
Overvaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Vitrolife AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling VITR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Vitrolife AB

Provide an overview of the primary business activities
of Vitrolife AB.

What unique competitive advantages
does Vitrolife AB hold over its rivals?

What risks and challenges
does Vitrolife AB face in the near future?

Summarize the latest earnings call
of Vitrolife AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vitrolife AB.

Provide P/S
for Vitrolife AB.

Provide P/E
for Vitrolife AB.

Provide P/OCF
for Vitrolife AB.

Provide P/FCFE
for Vitrolife AB.

Provide P/B
for Vitrolife AB.

Provide EV/S
for Vitrolife AB.

Provide EV/GP
for Vitrolife AB.

Provide EV/EBITDA
for Vitrolife AB.

Provide EV/EBIT
for Vitrolife AB.

Provide EV/OCF
for Vitrolife AB.

Provide EV/FCFF
for Vitrolife AB.

Provide EV/IC
for Vitrolife AB.

Show me price targets
for Vitrolife AB made by professional analysts.

What are the Revenue projections
for Vitrolife AB?

How accurate were the past Revenue estimates
for Vitrolife AB?

What are the Net Income projections
for Vitrolife AB?

How accurate were the past Net Income estimates
for Vitrolife AB?

What are the EPS projections
for Vitrolife AB?

How accurate were the past EPS estimates
for Vitrolife AB?

What are the EBIT projections
for Vitrolife AB?

How accurate were the past EBIT estimates
for Vitrolife AB?

Compare the revenue forecasts
for Vitrolife AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vitrolife AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vitrolife AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vitrolife AB compared to its peers.

Compare the P/E ratios
of Vitrolife AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Vitrolife AB with its peers.

Analyze the financial leverage
of Vitrolife AB compared to its main competitors.

Show all profitability ratios
for Vitrolife AB.

Provide ROE
for Vitrolife AB.

Provide ROA
for Vitrolife AB.

Provide ROIC
for Vitrolife AB.

Provide ROCE
for Vitrolife AB.

Provide Gross Margin
for Vitrolife AB.

Provide Operating Margin
for Vitrolife AB.

Provide Net Margin
for Vitrolife AB.

Provide FCF Margin
for Vitrolife AB.

Show all solvency ratios
for Vitrolife AB.

Provide D/E Ratio
for Vitrolife AB.

Provide D/A Ratio
for Vitrolife AB.

Provide Interest Coverage Ratio
for Vitrolife AB.

Provide Altman Z-Score Ratio
for Vitrolife AB.

Provide Quick Ratio
for Vitrolife AB.

Provide Current Ratio
for Vitrolife AB.

Provide Cash Ratio
for Vitrolife AB.

What is the historical Revenue growth
over the last 5 years for Vitrolife AB?

What is the historical Net Income growth
over the last 5 years for Vitrolife AB?

What is the current Free Cash Flow
of Vitrolife AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vitrolife AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vitrolife AB

Current Assets 2B
Cash & Short-Term Investments 947m
Receivables 645m
Other Current Assets 456m
Non-Current Assets 14.8B
Long-Term Investments 56m
PP&E 368m
Intangibles 14.3B
Other Non-Current Assets 131m
Current Liabilities 556m
Accounts Payable 164m
Accrued Liabilities 178m
Other Current Liabilities 214m
Non-Current Liabilities 3.1B
Long-Term Debt 2B
Other Non-Current Liabilities 1.1B
Efficiency

Earnings Waterfall
Vitrolife AB

Revenue
3.5B SEK
Cost of Revenue
-1.5B SEK
Gross Profit
2B SEK
Operating Expenses
-5.6B SEK
Operating Income
-3.6B SEK
Other Expenses
-255m SEK
Net Income
-3.8B SEK

Free Cash Flow Analysis
Vitrolife AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

VITR Profitability Score
Profitability Due Diligence

Vitrolife AB's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
48/100
Profitability
Score

Vitrolife AB's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

VITR Solvency Score
Solvency Due Diligence

Vitrolife AB's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
High Altman Z-Score
Low D/E
75/100
Solvency
Score

Vitrolife AB's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VITR Price Targets Summary
Vitrolife AB

Wall Street analysts forecast VITR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VITR is 233.33 SEK with a low forecast of 212.1 SEK and a high forecast of 278.25 SEK.

Lowest
Price Target
212.1 SEK
19% Upside
Average
Price Target
233.33 SEK
31% Upside
Highest
Price Target
278.25 SEK
57% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

VITR Price
Vitrolife AB

1M 1M
-7%
6M 6M
+15%
1Y 1Y
-24%
3Y 3Y
-42%
5Y 5Y
-9%
10Y 10Y
+672%
Annual Price Range
177.5
52w Low
127
52w High
241.4
Price Metrics
Average Annual Return 23.99%
Standard Deviation of Annual Returns 88.76%
Max Drawdown -77%
Shares Statistics
Market Capitalization 24B SEK
Shares Outstanding 135 447 008
Percentage of Shares Shorted
N/A

VITR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Vitrolife AB Logo
Vitrolife AB

Country

Sweden

Industry

Biotechnology

Market Cap

24B SEK

Dividend Yield

0.56%

Description

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

Contact

VASTRA GOTALANDS
Goeteborg
Gustaf Werners Gata 2
+46317218000.0
https://www.vitrolife.com/

IPO

2001-06-26

Employees

427

Officers

CEO & President
Ms. Bronwyn Brophy O´Connor
Chief Financial Officer
Mr. Patrik Tolf
Senior Vice President of Technologies
Mr. Claus Bisgaard
Vice President Strategy & Corporate development
Guillermo Ferrando
Senior Vice President of Sales & Marketing
Olivia Natens
Acting Senior Vice President of HR & Sustainability
Frank Pettersson
Show More
Senior Vice President of Consumables
Mr. Rickard Ericsson
Senior Vice President Genetic Services
Ricardo Capella
Show Less

See Also

Discover More
What is the Intrinsic Value of one VITR stock?

The intrinsic value of one VITR stock under the Base Case scenario is 143.96 SEK.

Is VITR stock undervalued or overvalued?

Compared to the current market price of 177.5 SEK, Vitrolife AB is Overvalued by 19%.